Advertisement
Screener

LEMAITRE VASCULAR, INC. (LMAT) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements

2.8 / 5 stars · 68/120 Roast Me

LEMAITRE VASCULAR, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements

LEMAITRE VASCULAR, INC. (LMAT) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $1.36 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2026-02-26

  • LEMAITRE VASCULAR, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2024-12-31 was $0.00.
  • LEMAITRE VASCULAR, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2024-09-30 was $0.00.
  • LEMAITRE VASCULAR, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2024-06-30 was $0.00.
  • LEMAITRE VASCULAR, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2024-03-31 was $0.00.
  • LEMAITRE VASCULAR, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2025 was $1.36M.
  • LEMAITRE VASCULAR, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2024 was $0.00.
  • LEMAITRE VASCULAR, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2023 was $0.00.
  • LEMAITRE VASCULAR, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2022 was $0.00.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month
2025-12-31$1.36M
10-K · filed 2026-02-26
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$0.00
10-K · filed 2026-02-26
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$0.00
derived: sum of 2 quarters · filed 2024-11-08
$0.00
10-Q · filed 2024-11-08
$0.00
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$0.00
10-Q · filed 2024-08-08
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$0.00
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$0.00
10-Q · filed 2024-05-10
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$0.00
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$0.00
10-K · filed 2026-02-26
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$0.00
derived: sum of 2 quarters · filed 2024-11-08
$0.00
10-Q · filed 2024-11-08
$0.00
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$0.00
10-Q · filed 2024-08-08
$0.00
derived: sum of 3 quarters · filed 2025-02-28
$0.00
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31$0.00
10-Q · filed 2024-05-10
$0.00
derived: sum of 2 quarters · filed 2025-02-28
$0.00
derived: sum of 3 quarters · filed 2025-02-28
$0.00
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$0.00
derived: sum of 2 quarters · filed 2025-02-28
$0.00
derived: sum of 3 quarters · filed 2025-02-28
$0.00
10-K · filed 2025-02-28
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$0.00
derived: sum of 2 quarters · filed 2023-11-07
$0.00
10-Q · filed 2023-11-07
$0.00
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$0.00
10-Q · filed 2023-08-08
$0.00
derived: sum of 3 quarters · filed 2024-02-29
$0.00
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$0.00
10-Q · filed 2023-05-09
$0.00
derived: sum of 2 quarters · filed 2024-02-29
$0.00
derived: sum of 3 quarters · filed 2024-02-29
$0.00
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$0.00
derived: sum of 2 quarters · filed 2024-02-29
$0.00
derived: sum of 3 quarters · filed 2024-02-29
$0.00
10-K · filed 2024-02-29
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$0.00
derived: sum of 2 quarters · filed 2022-11-08
$0.00
10-Q · filed 2022-11-08
$0.00
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
$0.00
10-Q · filed 2022-08-05
$0.00
derived: sum of 3 quarters · filed 2023-03-01
$0.00
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31$0.00
10-Q · filed 2022-05-10
$0.00
derived: sum of 2 quarters · filed 2023-03-01
$0.00
derived: sum of 3 quarters · filed 2023-03-01
$0.00
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$0.00
derived: sum of 2 quarters · filed 2023-03-01
$0.00
derived: sum of 3 quarters · filed 2023-03-01
$0.00
10-K · filed 2023-03-01
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$0.00
derived: sum of 2 quarters · filed 2021-11-04
$0.00
10-Q · filed 2021-11-04
$250.00K
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$0.00
10-Q · filed 2021-08-05
$250.00K
derived: sum of 3 quarters · filed 2022-02-28
$250.00K
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$0.00
10-Q · filed 2021-05-10
$250.00K
derived: sum of 2 quarters · filed 2022-02-28
$250.00K
derived: sum of 3 quarters · filed 2022-02-28
$276.00K
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$250.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$250.00K
derived: sum of 2 quarters · filed 2022-02-28
$276.00K
derived: sum of 3 quarters · filed 2022-02-28
$309.00K
10-K · filed 2022-02-28
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$26.00K
derived: sum of 2 quarters · filed 2020-11-06
$59.00K
10-Q · filed 2020-11-06
$87.00K
derived: sum of 4 quarters · filed 2021-03-12
2019-06-30$26.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$59.00K
10-Q · filed 2020-08-06
$87.00K
derived: sum of 3 quarters · filed 2021-03-12
$116.00K
derived: sum of 4 quarters · filed 2021-03-12
2019-03-31$33.00K
10-Q · filed 2020-05-08
$61.00K
derived: sum of 2 quarters · filed 2021-03-12
$90.00K
derived: sum of 3 quarters · filed 2021-03-12
$1.20M
derived: sum of 4 quarters · filed 2021-03-12
2018-12-31$28.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
$57.00K
derived: sum of 2 quarters · filed 2021-03-12
$1.16M
derived: sum of 3 quarters · filed 2021-03-12
$1.20M
10-K · filed 2021-03-12
2018-09-30$29.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
$1.14M
derived: sum of 2 quarters · filed 2019-11-08
$1.17M
10-Q · filed 2019-11-08
$1.21M
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30$1.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
$1.14M
10-Q · filed 2019-08-06
$1.18M
derived: sum of 3 quarters · filed 2020-03-12
$1.22M
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31$35.00K
10-Q · filed 2019-05-06
$71.00K
derived: sum of 2 quarters · filed 2020-03-12
$110.00K
derived: sum of 3 quarters · filed 2020-03-12
$138.00K
derived: sum of 4 quarters · filed 2020-03-12
2017-12-31$36.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
$75.00K
derived: sum of 2 quarters · filed 2020-03-12
$103.00K
derived: sum of 3 quarters · filed 2020-03-12
$126.00K
10-K · filed 2020-03-12
2017-09-30$39.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
$67.00K
derived: sum of 2 quarters · filed 2018-11-02
$90.00K
10-Q · filed 2018-11-02
2017-06-30$28.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06
$51.00K
10-Q · filed 2018-08-06
2017-03-31$23.00K
10-Q · filed 2018-05-04
2016-12-31$68.00K
10-K · filed 2019-03-11
2014-12-31$237.00K
10-K · filed 2017-03-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
NovoCure Ltd (NVCR)$1.886B-11.87
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77